The NHIS has raised the damage to KRW 1.2 billion for the GSK and Dong-A ST’s price fixing

Published: 2015-03-06 10:22:01

Updated: 2015-03-06 10:22:01

The National Health Insurance Service (NHIS) recomputed damages at KRW 1.2 billion for the lawsuit against GlaxoSmithKline and Dong-A ST that has fixed the price of the antiemetic treatment ‘Ondaron’.

“GSK and Dong-A ST stopped selling Ondaron, the generic, to distribute the original that is more expensive and wasted unnecessary budgets of the National Health Insurance,” the NHIS stated on the...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.